Clinical Trial Update: A Phase I/II Study of WJ13404 Monotherapy in Patients With Advanced or Mentastatic Non-Small Cell Lung Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase I/II study of WJ13404 as monotherapy for locally advanced or metastatic non-small cell lung cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• WJ13404

Snippet

Sponsor: Suzhou Junjing BioSciences Co., Ltd. | Conditions: Locally Advanced or Metastatic NSCLC | Phase 1, Phase 2 | Status: TERMINATED